Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Featured Companies
All Companies(60)
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Beacon Biosignals
Beacon Biosignals is a precision neuroscience platform that uses AI-powered technology to accelerate drug development and power home sleep testing diagnostics. The company collects, integrates, and analyzes EEG data across the full drug development lifecycle.
C2i Genomics
C2i Genomics develops AI-powered whole genome sequencing technology for cancer detection and monitoring. The company's platform enables ultra-sensitive minimal residual disease detection and early cancer screening through comprehensive genomic analysis.
Cancer Genetics
SOPHiA GENETICS provides an AI-driven, cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders. The company connects a global network of healthcare institutions to deliver precision medicine through advanced genomic and multimodal data analysis.
Clairity
Clairity develops FDA-authorized AI technology that predicts a woman's five-year breast cancer risk using only existing screening mammograms. The platform analyzes imaging data at the pixel level to identify patterns invisible to the human eye, enabling personalized prevention strategies.
Color Genomics
Color Health operates a Virtual Cancer Clinic delivering oncologist-led cancer care from screening and diagnosis through treatment and survivorship. The ASCO-certified platform serves employers, health plans, unions, and public sector organizations nationwide.
ConcertAI
ConcertAI orchestrates clinical expertise, real-world data, and applied AI to deliver practical intelligence for oncology and other complex diseases. The company serves life sciences, pharma, healthcare systems, and oncology providers with solutions spanning real-world evidence, clinical trials, commercial intelligence, and enterprise imaging.
Congenica
AI-powered genomic analysis platform for clinical interpretation of genetic variants and precision medicine decision support.
Dante Labs
Dante Labs provides clinical-grade whole genome sequencing services for individuals and physicians. The company sequences complete genomes at 30X coverage and delivers 200+ physician-ready reports covering hereditary risk, unexplained symptoms, treatment optimization, and proactive health insights.
Deep Genomics
Deep Genomics is an AI therapeutics company that uses its BioFM Model Platform to discover novel targets and design life-changing genetic medicines for patients.
DNAnexus
DNAnexus provides a cloud-based precision health data platform where multiomics data and AI converge to accelerate scientific breakthroughs. The platform enables biomedical organizations to manage, analyze, and collaborate on multimodal genomic and clinical data with regulatory-grade security.
Element Biosciences
Element Biosciences develops innovative genetic analysis tools, empowering the scientific community with freedom and flexibility to accelerate biological discoveries.
Emedgene
Emedgene, now part of Illumina, provides AI-driven software for germline variant interpretation in clinical genomics. The platform accelerates genetic disease diagnosis by automating variant analysis and classification for genetic testing laboratories and healthcare providers.
Exact Sciences
Exact Sciences develops innovative cancer screening, diagnostic, and therapy guidance tests. The company offers solutions for cancer prevention, early detection through multi-cancer screening, and personalized treatment guidance using genomic testing and molecular diagnostics.
Fabric Genomics
Fabric Genomics provides AI-powered genomic interpretation software and clinical services for clinical labs, hospital systems, and country-sequencing programs. The company's Fabric Enterprise platform enables rapid, accurate analysis of whole genome, exome, and panel tests to accelerate rare disease diagnosis and precision medicine.
Fairtility
Fairtility appears to be a company operating in the Precision Medicine & Genomics space focused on fertility-related healthcare solutions.
Foundation Medicine
Foundation Medicine is a precision medicine company transforming cancer care by providing high-quality, transformative diagnostic solutions.
Freenome AI
Freenome develops blood-based cancer screening tests using multiomics technology and artificial intelligence. The company focuses on detecting cancer in its earliest, most treatable stages through a simple blood draw, starting with colorectal cancer screening.
Fulgent Genetics
Fulgent Genetics is a full-service genomic testing company offering over 18,000 genetic tests across oncology, rare diseases, infectious diseases, and reproductive health. Founded in 2011, the company operates CLIA-certified and CAP-accredited laboratories across the United States.
Galatea Bio
Galatea Bio is a genomics company developing AI-powered tools to analyze genetic data and identify disease risk factors for precision medicine.
GeneDx AI
GeneDx provides comprehensive genomic testing including whole exome and whole genome sequencing to diagnose rare and inherited conditions. Trusted by over 75,000 clinicians, the company has performed 2.5+ million genetic tests, creating one of the world's largest rare disease datasets.
Geneoscopy
Geneoscopy develops noninvasive stool-based molecular diagnostic tests for gastrointestinal diseases. The company's proprietary stool-derived eukaryotic RNA (seRNA) technology platform enables screening for colorectal cancer and monitoring of inflammatory bowel disease.
Genomenon
Genomenon structures biomedical literature into real-world evidence for precision medicine programs and clinical labs. The company provides AI-powered literature search and expert-curated genomic evidence to accelerate drug development, expand disease insights, and enable faster, more accurate genetic diagnoses.
Genomic Prediction
Genomic Prediction provides advanced genetic testing and polygenic risk scoring for embryo screening in IVF, helping prospective parents make informed reproductive decisions.
GenomOncology
GenomOncology transforms complex and fragmented oncology data into actionable intelligence for precision medicine. The platform provides molecular pathology workbenches, clinical trial matching, and data enablement solutions for oncology professionals.
Genoox
Genoox provides genomic data management and analysis platforms for precision medicine, enabling healthcare organizations and researchers to interpret genetic variants and integrate genomic insights into clinical workflows.
Grail
GRAIL develops multi-cancer early detection (MCED) blood tests using next-generation sequencing and machine learning. The Galleri test screens for signals from 50+ cancer types, including many without existing routine screening options.
Guardant
Guardant Health is a precision oncology company that develops blood-based tests for cancer screening, diagnosis, and treatment monitoring. Their portfolio includes Shield for colorectal cancer screening, Guardant360 for comprehensive genomic profiling, and Guardant Reveal for minimal residual disease detection.
Helix
Helix is the leading enterprise genomics platform that transforms health systems and enables life science organizations to leverage the power of genomics across their enterprise. The company connects patients to affordable genetic insights, physicians to seamless ordering, health systems to scalable precision medicine infrastructure, and life sciences to the largest and fastest growing precision health network in the world.
Immunai
Immunai maps the immune system at unprecedented scale and resolution using AI-driven single-cell multiomics. The company partners with biopharmaceutical companies to support drug discovery and development decisions across target discovery, preclinical evaluation, and clinical trial optimization.
Invitae
Invitae, now part of Labcorp, provides comprehensive genetic testing services across oncology, women's health, cardiology, neurology, and rare diseases. The company has served over 5 million patients, offering accessible DNA testing with built-in genetic counseling to inform personalized healthcare decisions.
Lifebit
Lifebit provides federated Trusted Research Environment (TRE) technology that enables secure, in-place analysis of health data at population scale. The platform powers AI and research over 275M+ patient records without moving data, serving pharma, health systems, government, and data providers.
LunaDNA
LunaDNA is a community-owned health and DNA data platform that enables individuals to share their health information for research while maintaining ownership and receiving compensation.
Myriad Genetics
Myriad Genetics is a leading precision medicine company offering genetic and genomic testing across hereditary cancer risk, cancer treatment, reproductive health, mental health, and prostate cancer management. The company provides actionable insights to help patients and providers detect health risks, tailor treatments, and prevent disease.
Natera
Natera is a global leader in cell-free DNA testing, providing molecular diagnostics across oncology, women's health, organ health, and rare disease. The company's tests help identify disease risk, detect recurrence, and inform personalized treatment decisions.
NeoGenomics
NeoGenomics is a leading oncology diagnostics company providing comprehensive cancer testing services including genomic profiling, molecular diagnostics, and minimal residual disease (MRD) detection. The company serves healthcare providers, biopharma partners, and patients with over 500 tests across all major testing modalities.
Personalis
Personalis is a precision oncology company that develops advanced genomic sequencing and analysis technologies for cancer detection, monitoring, and treatment optimization. The company serves oncology researchers, biopharmaceutical companies, and healthcare providers with comprehensive tumor and liquid biopsy solutions.
Pierian
Pierian provides clinical genomics interpretation and reporting software for precision medicine. The company offers CGW (Clinical Genomics Workspace), a platform that helps laboratories and healthcare organizations analyze genomic data and generate clinical reports for cancer and rare disease diagnostics.
Predicine
Predicine develops next-generation liquid biopsy platforms for precision oncology, analyzing cell-free DNA and RNA from blood and urine samples. The company provides comprehensive genomic profiling assays and biomarker solutions to support biopharmaceutical clinical trials and cancer treatment decisions.
Prenosis
Prenosis develops AI-powered precision medicine tools for acute care conditions. The company's flagship product, Sepsis ImmunoScore, is the first FDA-authorized AI diagnostic for sepsis detection and prediction of adverse outcomes.
Q Bio
Q Bio delivers the Q Exam, a comprehensive longitudinal physical exam combining whole-body MRI, 120+ biomarkers, genetics, wearable data, and physician review into a single baseline record that compounds with every visit.
Quantum-Si
Quantum-Si pioneers next-generation protein sequencing (NGPS) technology that enables single-molecule, single-amino acid resolution protein analysis. Their flagship Platinum and Platinum Pro benchtop instruments make advanced proteomics accessible to academic, biotech, and pharmaceutical labs without requiring specialized expertise or dedicated lab space.
Sema4
GeneDx (formerly Sema4) provides comprehensive genomic testing including whole exome and whole genome sequencing for rare and inherited disease diagnosis. Trusted by over 75,000 clinicians, the company has performed 2.5+ million genetic tests and maintains one of the world's largest rare disease datasets.
SEngine Precision Medicine
SEngine Precision Medicine appears to be a company focused on precision medicine and genomics solutions. Based on the limited website content available, the company operates in the healthcare technology sector with a focus on personalized medicine approaches.
Seven Bridges
Seven Bridges (now part of Velsera) provides cloud-based bioinformatics platforms and software for genomic and clinical data analysis. The company delivers end-to-end solutions including access to datasets, analytic workflows, cloud computing infrastructure, and scientific support to accelerate biomedical research and precision medicine.
SimBioSys
SimBioSys develops AI-powered 3D tumor visualization and predictive modeling technology for precision cancer care. Their FDA-cleared TumorSight platform transforms 2D medical imaging into interactive 3D digital twins to support surgical planning and treatment decisions.
SOPHiA GENETICS
SOPHiA GENETICS provides an AI-driven, cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders. The company connects 990+ healthcare institutions across 75+ countries, having analyzed 2.5M+ genomic profiles.
Tempus
Tempus AI applies artificial intelligence to clinical and molecular data to advance precision medicine, helping physicians make data-driven decisions for personalized patient care.
Tune Therapeutics
Tune Therapeutics pioneers epigenetic editing technology to treat complex diseases without altering DNA sequences. Their TEMPO platform enables precise control of gene expression—activating, silencing, or fine-tuning genes to address chronic, age-related, and previously intractable conditions.
Variantyx
Variantyx is a molecular diagnostics company providing comprehensive genetic testing for rare genetic disorders, reproductive genetics, and precision oncology using advanced whole genome sequencing technology.
Veracyte
Veracyte develops high-performing molecular diagnostic tests that assess the unique biology of each patient's tumor to guide cancer care decisions. The company's genomic tests help clinicians make confident treatment decisions for thyroid, prostate, breast, bladder, and lung cancer patients.
Verily
Verily is a precision health AI company that transforms multimodal health data into insights and actions. The company offers AI-enabled solutions that accelerate research, enable personalized care, and help manage disease at population levels through its Pre platform.
Related Articles
All News →
Alphabet's AI Scans Sewage at World Cup to Predict Disease Outbreaks Before Symptoms Emerge
Verily deploys wastewater surveillance technology across World Cup host cities to detect disease outbreaks up to a week before symptoms appear in populations.
What Healthcare AI Can Learn From Vertical AI in Construction
The health AI industry's most durable companies will be those that go deepest in a single clinical domain — not the ones that build the most general-purpose platform. The success of vertical AI in adjacent industries offers a clear template.
Tempus AI Reports 75% Revenue Growth in Q1 2026, Driven by Genomics and Data Licensing
Tempus AI has reported first-quarter 2026 revenue of $255 million, a 75% increase year-over-year, driven by strong growth in its genomics testing and data licensing segments as the company continues its post-IPO expansion.
Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical Foundation Model
Aidoc has closed a $150 million Series E round led by Goldman Sachs, with participation from existing investors, to scale its CARE clinical AI foundation model and expand its presence in radiology and emergency medicine workflows globally.